Gene · 5106
Papers3,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring Toxicity of Per- and Polyfluoroalkyl Substances (PFAS) Mixture Through ADMET and Toxicogenomic In Silico Analysis: Molecular Insights. | Int J Mol Sci | 2024 | 39596398 | PubTator, text mining | PubMed |
| The Telomere-to-Telomere Genome of Jaboticaba Reveals the Genetic Basis of Fruit Color and Citric Acid Content. | Int J Mol Sci | 2024 | 39596019 | PubTator, text mining | PubMed |
| Milk fat globule membranes ameliorate diet-induced obesity in mice by modulating glucolipid metabolism, body inflammation, and oxidative stress. | Food Funct | 2024 | 39584542 | PubTator, text mining | PubMed |
| AuCePt porous hollow cascade nanozymes targeted delivery of disulfiram for alleviating hepatic insulin resistance. | J Nanobiotechnology | 2024 | 39456019 | PubTator, text mining | PubMed |
| Lactylation-Driven IGF2BP3-Mediated Serine Metabolism Reprogramming and RNA m6A-Modification Promotes Lenvatinib Resistance in HCC. | Adv Sci (Weinh) | 2024 | 39450426 | PubTator, text mining | PubMed |
| Glycogenesis and glyconeogenesis from glutamine, lactate and glycerol support human macrophage functions. | EMBO Rep | 2024 | 39424955 | PubTator, text mining | PubMed |
| DNA 5mC and RNA m6A Collaborate to Upregulate Phosphoenolpyruvate Carboxykinase 2 for Kupffer Cell Activation. | Int J Mol Sci | 2024 | 39337381 | PubTator, text mining | PubMed |
| Antidiabetic and Antihyperlipidemic Activities and Molecular Mechanisms of Phyllanthus emblica L. Extract in Mice on a High-Fat Diet. | Curr Issues Mol Biol | 2024 | 39329975 | PubTator, text mining | PubMed |
| Unraveling the relevance of SARS-Cov-2 infection and ferroptosis within the heart of COVID-19 patients. | Heliyon | 2024 | 39263089 | PubTator, text mining | PubMed |
| Strategy for treating MAFLD: Electroacupuncture alleviates hepatic steatosis and fibrosis by enhancing AMPK mediated glycolipid metabolism and autophagy in T2DM rats. | Diabetol Metab Syndr | 2024 | 39261952 | PubTator, text mining | PubMed |
| Phylogenetic synthesis of morphological and molecular data reveals insights on the classification of diogenid hermit crabs (Crustacea: Decapoda: Anomura). | PeerJ | 2024 | 39221280 | PubTator, text mining | PubMed |
| Nine new nor-3,4-seco-dammarane triterpenoids from the leaves of Cyclocarya paliurus and their hypoglycemic activity. | Bioorg Chem | 2024 | 39216195 | PubTator, text mining | PubMed |
| Inter-organ differences in redox imbalance and apoptosis depict metabolic resilience in migratory redheaded buntings. | Sci Rep | 2024 | 39215166 | PubTator, text mining | PubMed |
| Insight in the (Phospho)proteome of Vascular Smooth Muscle Cells Derived From Patients With Abdominal Aortic Aneurysm Reveals Novel Disease Mechanisms. | Arterioscler Thromb Vasc Biol | 2024 | 39206541 | PubTator, text mining | PubMed |
| Protopanaxadiol derivative: A plant origin of novel selective glucocorticoid receptor modulator with anti-inflammatory effect. | Eur J Pharmacol | 2024 | 39181225 | PubTator, text mining | PubMed |
| Phosphoenolpyruvate carboxykinase-2 (PCK2) is a therapeutic target in triple-negative breast cancer. | Breast Cancer Res Treat | 2024 | 39177932 | PubTator, text mining | PubMed |
| Uncovering underlying physical principles and driving forces of cell differentiation and reprogramming from single-cell transcriptomics. | Proc Natl Acad Sci U S A | 2024 | 39150785 | PubTator, text mining | PubMed |
| Effects of undescribed iridoids in Patrinia punctiflora on insulin resistance in HepG2 cells. | Fitoterapia | 2024 | 39098734 | PubTator, text mining | PubMed |
| GHSR signalling in perinatal phases is involved in liver metabolism at puberty. | J Endocrinol | 2024 | 39045853 | PubTator, text mining | PubMed |
| Targeting SOX4/PCK2 signaling suppresses neuroendocrine trans-differentiation of castration-resistant prostate cancer. | Biol Direct | 2024 | 39014441 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5106/papers?page=8